Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death

K Kim1

  • 1Department of Pathology, University of Washington, Seattle, Washington 98195, USA. koanhoi@u.washington.edu

Insights

Proteasome activity is crucial for vascular smooth muscle cell (VSMC) survival. Inhibiting proteasomes enhances VSMC susceptibility to Fas-mediated death by influencing Fas signaling pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Vascular smooth muscle cells (VSMCs) play a critical role in cardiovascular health.
  • Fas-mediated apoptosis is a key pathway regulating cell death.
  • The role of proteasome activity in VSMC susceptibility to Fas-mediated death remains unclear.

Purpose of the Study:

  • To investigate the role of proteasome activity in human VSMC susceptibility to Fas-mediated apoptosis.
  • To elucidate the mechanisms by which proteasome inhibition affects Fas signaling in VSMCs.

Main Methods:

  • Human fetal aorta smooth muscle cells were treated with agonistic anti-Fas antibody (CH11) and proteasome inhibitors (MG115 or MG132).
  • Cell death was assessed using morphology, viability assays, and DNA fragmentation analysis.
  • Western blotting was used to determine the expression levels of key proteins involved in apoptosis signaling.

Main Results:

  • Proteasome inhibition, in conjunction with anti-Fas antibody, induced VSMC death and DNA degradation, which was blocked by a caspase inhibitor.
  • Co-treatment with anti-Fas antibody and proteasome inhibitors activated caspase-3.
  • Proteasome inhibitors did not alter the expression of procaspase-8, procaspase-3, c-FLIP, or Bcl-2, but upregulated Fas and FADD expression.

Conclusions:

  • Proteasome activity is essential for VSMC survival.
  • This study provides the first evidence linking proteasome function to Fas signal transduction in VSMCs.
  • Novel mechanisms are proposed for VSMC susceptibility to Fas ligand-induced apoptosis under proteasome inhibition.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...